π¬ Current Disease Focus:
Task Progress: 0%
π₯ Active Problem Solvers
0
π Experts collaborating globally
β‘ Current Task Assignment
𧬠Genetic Analysis
π Matching experts to specific tasks
π Resource Allocation by Research Phase:
π Data Analysis
π§ͺ Experimental Design
π¬ Clinical Trials
π Treatment Development
This clinical trial examines sustained oral fiber supplementation for patie...
Status
Recruiting
Location
Fred Hutch/University of Washington Cancer Consortium
Start Date
2022-06-22
Trial ID
NCT04829136
This case-control study will be conducted between January and June 2026 and...
Status
Enrolling By Invitation
Location
University of babylon
Start Date
2026-01-31
Trial ID
NCT07579338
RATIONALE: Erlotinib may stop the growth of tumor cells by blocking some of...
Status
Completed
Location
University Hospitals Cleveland Medical Center, Case Comprehensive Cancer Center
Start Date
2007-11-19
Trial ID
NCT00720304
Treatments Being Tested
Upadacitinib sustained-release tablets have not yet been approved for the t...
Status
Active Not Recruiting
Location
Tianjin Eye hospital
Start Date
2025-01-01
Trial ID
NCT07773623
Treatments Being Tested
This study aimed to investigate gingival crevicular fluid (GCF) and serum l...
Status
Completed
Location
Giresun University
Start Date
2019-09-30
Trial ID
NCT04383561
Treatments Being Tested
In Switzerland, the most commonly performed bariatric procedure is the prox...
Status
Withdrawn
Location
Multiple Locations
Start Date
2022-01-01
Trial ID
NCT04423588
Treatments Being Tested
This study aims to collect serum samples from healthy non-pregnant women, p...
Status
Unknown
Location
Women's Hospital School Of Medicine Zhejiang University
Start Date
2023-07-18
Trial ID
NCT05881616
A prospective, mono-center, interventional study evaluating the effect of o...
Status
Completed
Location
CHU Rennes
Start Date
2019-06-11
Trial ID
NCT03942432
Treatments Being Tested
This is a 2-part, open label, fixed-sequence study to evaluate the potentia...
Status
Completed
Location
Clinical Trial Site
Start Date
2021-06-07
Trial ID
NCT04933682
Treatments Being Tested
Determine the doses and schedule appropriate for phase 2 study of sorafenib...
Status
Completed
Location
Virginia Commonwealth University/Massey Cancer Center
Start Date
2015-01-29
Trial ID
NCT02349867